ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OMCL Omnicell Inc

27.17
0.36 (1.34%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Omnicell Inc NASDAQ:OMCL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.36 1.34% 27.17 27.17 28.50 27.72 26.59 26.88 459,822 00:55:35

Statement of Changes in Beneficial Ownership (4)

22/10/2019 12:01am

Edgar (US Regulatory)


FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

LIPPS RANDALL A
2. Issuer Name and Ticker or Trading Symbol

OMNICELL, Inc [ OMCL ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chairman, President and CEO
(Last)          (First)          (Middle)

C/O OMNICELL, INC., 590 E.MIDDLEFIELD
3. Date of Earliest Transaction (MM/DD/YYYY)

10/18/2019
(Street)

MOUNTAIN VIEW, CA 94043
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                 128487  D   
Common Stock                 294409  I  In Trust with Wife (1)
Common Stock                 7776  I  In Trust for Children (2)
Common Stock  10/18/2019    S    1100 (1)(3) D $75.1718 (4) 293309  I  In Trust with Wife 
Common Stock  10/18/2019    S    3500 (1)(3) D $76.2189 (5) 289809  I  In Trust with Wife 
Common Stock  10/18/2019    S    400 (1)(3) D $76.8675 (6) 289409  I  In Trust with Wife 
Common Stock  10/21/2019    M    25926 (3) A $0  154413  D   
Common Stock  10/21/2019    S    25926 (3) D $78.0294 (7) 128487  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options NQ (Right to Buy)  $27.70  10/21/2019    M        25926   2/4/2017  2/3/2026  Common Stock  25926  $0  0  D   

Explanation of Responses:
(1)  Shares held in trust with Mr. Lipps' wife.
(2)  Shares held in trust for the benefit of Mr. Lipps' children.
(3)  The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan
(4)  The price reported in Column 4 is the average price of $75.1718. The sold price range between $74.64 to $75.6399. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(5)  The price reported in Column 4 is the average price of $76.2189. The sold price range between $75.65 to $76.6499. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(6)  The price reported in Column 4 is the average price of $76.8675. The sold price range between $76.72 to $77.7199. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(7)  The price reported in Column 4 is the average price of $78.0294. The sold price range between $78.00 to $78.21. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
LIPPS RANDALL A
C/O OMNICELL, INC.
590 E.MIDDLEFIELD
MOUNTAIN VIEW, CA 94043
X
Chairman, President and CEO

Signatures
/s/ Randall A. Lipps 10/21/2019
**Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Omnicell Chart

1 Year Omnicell Chart

1 Month Omnicell Chart

1 Month Omnicell Chart

Your Recent History

Delayed Upgrade Clock